56 filings
8-K
PSTX
Poseida Therapeutics Inc
14 May 24
Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2024
4:06pm
8-K
PSTX
Poseida Therapeutics Inc
1 May 24
Entry into a Material Definitive Agreement
9:07am
8-K
PSTX
Poseida Therapeutics Inc
17 Apr 24
Poseida Therapeutics Hosts Gene Therapy R&D Day Highlighting New Scientific Advancements and Pipeline Focus
9:17am
8-K
PSTX
Poseida Therapeutics Inc
8 Apr 24
Regulation FD Disclosure
4:30pm
8-K
PSTX
Poseida Therapeutics Inc
7 Mar 24
Poseida Therapeutics Provides Updates and Financial Results for the Fourth Quarter and Full Year 2023
4:05pm
8-K
pdkfyzohqnf5
4 Jan 24
Departure of Directors or Certain Officers
4:01pm
8-K
stq6 tdlp
11 Dec 23
Regulation FD Disclosure
6:06am
8-K
34r66c5v9oweckiwse95
9 Nov 23
Poseida Therapeutics Provides Updates and Financial Results for the Third Quarter of 2023
4:05pm
8-K
p2q4a3g
10 Oct 23
Departure of Directors or Certain Officers
12:00am
8-K
b672y9 8ry9reojqx
8 Aug 23
Poseida Therapeutics Provides Financial Results for the Second Quarter of 2023
4:06pm
8-K
mqijfx2y
7 Aug 23
Astellas and Poseida Therapeutics Announce Strategic
9:01am
8-K
k693d cqflr1f
16 Jun 23
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
2xrf03rb1w4s4xx
1 Jun 23
Termination of a Material Definitive Agreement
4:30pm
8-K
odv6wm56
9 May 23
Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2023
4:06pm
8-K
rb2ca8
13 Apr 23
Departure of Directors or Certain Officers
8:06am
8-K
vhh7p8bfr g6
30 Mar 23
Changes in Registrant's Certifying Accountant
5:19pm
8-K
2ldkdjk
9 Mar 23
Poseida Therapeutics Provides Updates and Financial Results for the Fourth Quarter and Full Year 2022
4:05pm
8-K
9amdn64l9
22 Feb 23
Regulation FD Disclosure
8:08am
8-K
yhtcr
31 Jan 23
Poseida Therapeutics Announces Board Change
4:46pm
8-K
598pohi97ktxzi4 zuq
6 Dec 22
Poseida Therapeutics to Present Early Data from Phase 1 Trials of P-MUC1C-ALLO1 and P-BCMA-ALLO1 at ESMO Immuno-Oncology 2022 Annual Congress
6:06am